Related Experiment Video
Updated: Jan 30, 2026
07:22
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
4.5K
Proteolysis-targeting chimeras for targeting protein for degradation
1Key Laboratory of Natural Medicine & Immuno-Engineering of Henan Province, Henan University Jinming Campus, Kaifeng 475004, PR China.
Future Medicinal Chemistry
|February 2, 2019
Summary
Proteolysis-targeting chimeras (PROTACs) offer a novel therapeutic approach by degrading disease-causing proteins. This review highlights recent PROTACs and their advantages over traditional enzyme inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Proteolysis-targeting chimeras (PROTACs) represent a new therapeutic modality.
- PROTACs leverage the ubiquitin-proteasome system for targeted protein degradation.
Purpose of the Study:
- To review recent advancements in PROTAC technology.
- To discuss the therapeutic potential of PROTACs compared to conventional enzyme inhibitors.
Main Methods:
- Literature review of recently reported PROTAC molecules.
- Comparative analysis of PROTACs and enzyme inhibitors.
Main Results:
- PROTACs are bifunctional molecules inducing targeted protein degradation.
- Recent PROTACs show promise for therapeutic intervention.
- PROTACs offer potential benefits over classical enzyme inhibition.
Conclusions:
- PROTACs are a promising therapeutic strategy for disease treatment.
- Future research should address PROTAC delivery and bioavailability challenges.
- High molecular weight of PROTACs necessitates further investigation into formulation and delivery.
Related Concept Videos
02:58Regulated Protein Degradation
8.8K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
02:58Regulated Protein Degradation
3.2K
3.2K
02:11Proteins: From Genes to Degradation
14.5K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.5K
02:11Proteins: From Genes to Degradation
4.5K
4.5K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:26Targets for Drug Action: Overview
10.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.2K